Beijing Biotech

This study is testing a new type of treatment called CAR-NK cell therapy for people with advanced breast cancer that has stopped responding to standard treatments. Doctors will collect a patient's own natural immune cells, modify them in a lab to better recognize and attack cance…

This study is testing a new type of immune cell therapy for adults with advanced liver cancer that cannot be removed by surgery or has returned after other treatments. Doctors will give patients specially engineered immune cells designed to find and attack cancer cells. The study…

This early-stage trial is testing a new type of cell therapy for people with advanced lung cancer that has spread and no longer responds to standard treatments. The therapy uses specially modified 'natural killer' immune cells designed to recognize and attack cancer cells that ha…

This early-stage trial is testing a new type of treatment using specially engineered immune cells, called CAR-NK cells, for people with advanced pancreatic cancer that has spread or cannot be removed by surgery. The study aims to find a safe dose and see if the treatment can shri…

This is a first-in-human study testing a new type of cell therapy for adults with recurrent or progressive glioblastoma or other high-grade brain tumors. The therapy uses modified natural killer (NK) immune cells designed to recognize two specific markers on the patient's tumor. …

This study is testing a new type of treatment called CAR-NK cell therapy for women with ovarian cancer that has come back or stopped responding to standard treatments. Doctors first check the patient's tumor for specific markers and then give them a personalized infusion of modif…

This study is testing a new type of cell therapy for adults with advanced or metastatic colorectal cancer that has stopped responding to standard treatments. Doctors will give patients immune cells (CAR-NK cells) that are engineered to recognize and attack two specific proteins f…